A Smartphone Application for Added Psychological Wellbeing in Crohn's Disease — COBMINDEX  

Crohn Disease Clinical Trial

Official title: Israeli IBD Research Nucleus (IIRN) Consortium: COBMINDEX Goes Forward- A Smartphone Application for Added Psychological Wellbeing in Crohn's Disease

Status Recruiting

Clinical Trial Summary

Psychological intervention by COBMINDEX application to reduce psychological stress among CD patients, fatigue and pain and improve the patients' well being, quality-of-life and disease-coping skills, as well as improvement of the patients' immunological profile and intestinal microbiome.

Clinical Trial Description

200 patients will be randomly divided into two groups - 100 patients will learn and practice COBMINDEX by a human therapist-social worker and 100 patients will learn and practice COBMINDEX by a digital therapist using the COBMINDEX application.

In the first 3-months there will be an assessment of patient progress following randomization to human therapist or digital therapist using the application for learning and practicing. During this period, the group of the human social-worker will have a limited access to the application dedicated for daily exercises and assessment.

In the following 9-month period, all patients will practice using the application, each group by it's permissions.

There will be daily assessment of stress, pain, fatigue, well-being and frequent assessments of patients' medical, psychological, and immunological status.

Throughout the trial, adverse events and concomitant medications will be collected. ;

Related Conditions & MeSH terms

• Crohn Disease

• NCT number: NCT06221254
• Study type: Interventional
• Source: Soroka University Medical Center
• Contact: Doron Schwartz, MD
• Phone: +972-52-3919044
• Email: DoronSh@clalit.org.il
• Status: Recruiting
• Phase: N/A
• Start date: August 1, 2023
• Completion date: August 1, 2026